Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Stockton (Israel) Ltd. currently manages a patent portfolio focused within the Biotechnology & Pharmaceuticals technology area. The prosecution activity is highly concentrated, as evidenced by the presence of 1 pending office action. This single active matter defines the current administrative load for the company legal team in this specific sector. The focus on a single action suggests a deliberate and targeted approach to their current intellectual property strategy.
The examination phase is characterized by a narrow distribution across the United States Patent and Trademark Office. The portfolio involves 1 distinct examiner and 1 distinct art unit. Such a focused arrangement suggests that the company filings are confined to a specific technical niche within the broader biotechnology field, rather than being spread across multiple disparate regulatory groups. This concentration allows for a unified prosecution strategy that does not need to account for varying examiner behaviors across different art units.
GAREN GOTFREDSON is identified as the busiest examiner for this portfolio, currently handling 1 pending office action. This individual represents the entirety of the company active examination interface. For a practitioner, this means that the outcome of the current prosecution efforts depends solely on the interactions with this one examiner. The fact that the busiest examiner pending count is 1 aligns with the total volume of active actions, indicating no fragmentation in the current workload and allowing for a direct line of communication with the patent office.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOTFREDSON, GAREN | 1 | 40.0% | +28.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17639770 | TEA TREE OIL FOR INDUCING SYSTEMIC RESISTANCE IN PLANTS | GOTFREDSON, GAREN | 15d |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17639770 | TEA TREE OIL FOR INDUCING SYSTEMIC RESISTANCE IN PLANTS | GOTFREDSON, GAREN | 1619 | §103 | Final Rejection | 15d | Pending | Mar 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial